EPO published patent application EP4299591A1 titled 'Preparation of Siglec-15 Binding Protein and Use Thereof' filed by Shanghai Jemincare Pharmaceuticals. The application covers C07K 16/28 (antibodies), C12N 15/13 (gene sequences), and therapeutic use for cancer treatment (A61P 35/00). The inventors include YANG, Xinxiu, GU, Chunyin, WANG, Zongda, and others. Designated states include all major EPC contracting states (DE, FR, GB, IT, ES, NL, etc.).

This is a routine patent publication providing public notice of the application. No compliance actions are required from regulated entities. Pharmaceutical companies developing similar therapeutics or biosimilars should review the claims to assess freedom-to-operate. Healthcare providers and investors monitoring oncology pipeline developments may wish to track this application through prosecution to grant.